For the first time, researchers have managed to delay the onset of type 1 diabetes. In a breakthrough study, TrialNet was able to delay the onset by two years.
Stacey talks to Dr. Michael Haller in-depth about this and other studies. An excerpt of this interview ran in our previous episode. In this episode you’ll learn more about how TrialNet works, other promising studies and why it’s so difficult to prevent an auto-immune disease. Plus, an update on the funding for TrialNet and why they’ve changed how they re-screen families and individuals.
Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners!
Get the App and listen to Diabetes Connections wherever you go!